GAINESVILLE, Fla., Feb. 18, 2025 /PRNewswire/ — Exactech, a global leader in medical technology, presented 15 new studies describing new research and advancements in total joint arthroplasty and ...

Margins matter. The more Exactech (NAS: EXAC) keeps of each buck it earns in revenue, the more money it has to invest in growth, fund new strategic plans, or (gasp!) distribute to shareholders.

Margins matter. The more Exactech (NAS: EXAC) keeps of each buck it earns in revenue, the more money it has to invest in growth, fund new strategic plans, or (gasp!) distribute to shareholders.

Exactech is a medical device company that manufactures implantable joint replacements. It is also a company that has faced numerous lawsuits related to its products in recent years. In many cases, ...

Over the past couple of decades, hundreds of thousands of patients in the United States have received defective medical implants manufactured by Exactech. While the U.S. Food and Drug Administration ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

Producer of bone and joint restoration products, Exactech Inc. (EXAC) recently announced that it has acquired BlueOrtho SAS – a firm engaged in computer-assisted surgical technology development and ...

Margins matter. The more Exactech (Nasdaq: EXAC) keeps of each buck it earns in revenue, the more money it has to invest in growth, fund new strategic plans, or (gasp!) distribute to shareholders.

Exactech Inc. (Nasdaq: EXAC) has agreed to acquire Altiva Corp., a Charlotte, N.C.-based maker of spinal implant devices and related products. The deal represents Exactech's decision to exercise a ...

Christy Bieber has a JD from UCLA School of Law and began her career as a college instructor and textbook author. She has been writing full time for over a decade with a focus on making financial and ...

It takes money to make money. Most investors know that, but with business media so focused on the "how much," very few investors bother to ask, "How fast?" When judging a company's prospects, how ...

Medical devicemaker Exactech agreed to pay $8 million to settle allegations that it knowingly marketed and sold defective components within its line of Optetrak total knee systems, which have been ...